St Lukes Medical Pharmacy pharmacist Muhammad Hussaini says script numbers are down by 60-70 per cent and retail is "completely dead"
Eighteen months after New Zealand's first nationwide Alert Level 4 lockdown, Pharmacy Today reporters Jonathan Chilton-Towle and Anna Lee revisited, in a socially distanced way, pharmacy staff they interviewed last year to see how a year and a half has changed the pandemic landscape
‘We’ve got to stop doing lockdowns’, In the past year and a half, St Lukes Medical Pharmacy has lost most of its patients, prescriptions and retail sales, and has been forced to make six
Linda Bryant discusses gout, a chronic long-term condition that is often associated with other diseases, and drug-related morbidity and mortality. As such, gout needs to be addressed holistically as part of the psychosocial medical model
Patients can no longer be started on funded selegiline. Patients who were on selegiline prior to 1 August 2021 will need their prescriptions endorsed to receive subsidised supplies. An alternative MAO-B inhibitor, rasagiline, may be a suitable agent for new patients or those transitioning from selegiline.
This resource provides a timeline for the changes and information about transitioning patients from selegiline. Advice on prescribing rasagiline is also included.